Implications for 25-hydroxyvitamin D testing of public health policies about the benefits and risks of Vitamin D fortification and supplementation

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 72, Issue SUPPL. 243, 2012, Pages 144-153

  Vieth, Reinhold ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; COLECALCIFEROL; FOLIC ACID; IODINE; PLACEBO; VITAMIN D; 25-HYDROXYVITAMIN D; DRUG DERIVATIVE;

ARTICLE; BREAST CANCER; BREAST METASTASIS; CALORIC INTAKE; DENTAL CARIES; DIET SUPPLEMENTATION; FALLING; FRACTURE; HEALTH CARE POLICY; HIP FRACTURE; HUMAN; LACTOSE INTOLERANCE; MULTIPLE SCLEROSIS; NUTRITIONAL STATUS; PRIORITY JOURNAL; SIDE EFFECT; SUN EXPOSURE; VITAMIN SUPPLEMENTATION; BLOOD; CLINICAL TRIAL (TOPIC); PUBLIC HEALTH; RISK;

CLINICAL TRIALS AS TOPIC; DIETARY SUPPLEMENTS; FOOD, FORTIFIED; HEALTH POLICY; HUMANS; NUTRITION POLICY; PUBLIC HEALTH; RISK; VITAMIN D;

EID: 84860367626     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2012.682893     Document Type: Article

References (44)

1. Hathcock JN, Shao A, Vieth R, Heaney R. Risk assessment for vitamin D. Am J Clin Nutr 2007;85:6-18.
2. Bischoff-Ferrari HA, Shao A, wson-Hughes B, Hathcock J, Giovannucci E, Willett WC. Benefi t-risk assessment of vitamin D supplementation. Osteoporos Int 2010;21: 1121-32.
3. Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: The National Academies Press, 2011.
4. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999;69: 842-56.
5. Luxwolda MF, Kuipers RS, Kema IP, Janneke Dijck- Brouwer DA, Muskiet FA. Traditionally living populations in East Africa have a mean serum 25-hydroxyvitamin D concentration of 115 nmol/l. Br J Nutr 2012;1-5.
6. Aloia J, Bojadzievski T, Yusupov E et a l. The relative infl uence of calcium intake and vitamin D status on serum parathyroid hormone and bone turnover biomarkers in a double-blind, placebo-controlled parallel group, longitudinal factorial design. J Clin Endocrinol Metab 2010;95: 3216-24.
7. Amir E, Simmons CE, Freedman OC et a l. A phase 2 trial exploring the effects of high-dose (10,000 IU/day) vitamin D(3) in breast cancer patients with bone metastases. Cancer 2010;116:284-91.
8. Burton JM, Kimball S, Vieth R et a l. A phase I/II doseescalation trial of vitamin D3 and calcium in multiple sclerosis. Neurology 2010;74:1852-9.
9. El-Hajj Fuleihan G, Nabulsi M, Tamim H et al. Effect of vitamin D replacement on musculoskeletal parameters in school children: A randomized controlled trial. J Clin Endocrinol Metab 2006;91:405-12.
10. Hitz MF, Jensen JE, Eskildsen PC. Bone mineral density and bone markers in patients with a recent low-energy fracture: Effect of 1 y of treatment with calcium and vitamin D. Am J Clin Nutr 2007;86:251-9.
11. Jorde R, Sneve M, Figenschau Y, Svartberg J, Waterloo K. Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: Randomized double blind trial. J Intern Med 2008;264:599-609.
12. Jorde R, Sneve M, Hutchinson M, Emaus N, Figenschau Y, Grimnes G. Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. Am J Epidemiol 2010;171:903-8.
13. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. Vitamin D and calcium supplementation reduces cancer risk: Results of a randomized trial. Am J Clin Nutr 2007;85:1586-91.
14. Martineau AR, Timms PM, Bothamley GH et al. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: A double-blind randomised controlled trial. Lancet 2011;377:242-50.
15. Mitri J, wson-Hughes B, Hu FB, Pittas AG. Effects of vitamin D and calcium supplementation on pancreatic beta cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: The Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr 2011;94:486-94.
16. Mocanu V, Stitt PA, Costan AR et a l. Long-term effects of giving nursing home residents bread fortifi ed with 125 microg (5000 IU) vitamin D(3) per daily serving. Am J Clin Nutr 2009;89:1132-7.
17. Nagpal J, Pande JN, Bhartia A. A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet Med 2009;26:19-27.
18. Nursyam EW, Amin Z, Rumende CM. The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med Indones 2006;38:3-5.
19. Sanders KM, Stuart AL, Williamson EJ et a l. Annual high-dose oral vitamin D and falls and fractures in older women: A randomized controlled trial. JAMA 2010;303: 1815- 22.
20. Smith SM, Gardner KK, Locke J, Zwart SR. Vitamin D supplementation during Antarctic winter. Am J Clin Nutr 2009;89:1092-8.
21. Stubbs JR, Idiculla A, Slusser J, Menard R, Quarles LD. Cholecalciferol supplementation alters calcitriol-responsive monocyte proteins and decreases infl ammatory cytokines in ESRD. J Am Soc Nephrol 2010;21:353-61.
22. Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, Ida H. Randomized trial of vitamin D supplementation to prevent seasonal infl uenza A in schoolchildren. Am J Clin Nutr 2010;91:1255-60.
23. Vieth R, Kimball S, Hu A, Walfi sh PG. Randomized comparison of the effects of the vitamin D3 adequate intake versus 100 g (4000 IU) per day on biochemical responses and the wellbeing of patients. Nutr J 2004;3:8.
24. von Hurst PR, Stonehouse W, Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D defi cient- A randomised, placebo-controlled trial. Br J Nutr 2009;1-7.
25. Linseisen J, Bechthold A, Bischoff-Ferrari HA, Hintzpeter B, et al. Vitamin D und Pr ä vention ausgew ä hlter chronischer Krankheiten. Deutschen Gesellschaft für Ern ä hrung e. V. (DGE), 2011.
26. Tulchinsky TH, Kaluski DN, Berry EM. Food fortifi cation and risk group supplementation are vital parts of a comprehensive nutrition policy for prevention of chronic diseases. Eur J Public Health 2004;14:226-8.
27. Garriguet D. Bone health: Osteoporosis, calcium and vitamin D. Health Rep 2011;22:7-14.
28. Mursu J, Robien K, Harnack LJ, Park K, Jacobs DR, Jr. Dietary supplements and mortality rate in older women: The Iowa Women's Health Study. Arch Intern Med 2011;171: 1625-33.
29. Miller ER, III, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005;142:37-46.
30. Tanvetyanon T, Bepler G. Beta-carotene in multivitamins and the possible risk of lung cancer among smokers versus former smokers: A meta-analysis and evaluation of national brands. Cancer 2008;113:150-7.
31. Tylavsky FA, Cheng S, Lyytikainen A, Viljakainen H, Lamberg-Allardt C. Strategies to improve vitamin d status in northern European children: Exploring the merits of vitamin d fortifi cation and supplementation. J Nutr 2006; 136:1130-4.
32. Petrella RJ, Jones TJ. Do patients receive recommended treatment of osteoporosis following hip fracture in primary care? BMC Fam Pract 2006;7:31.
33. Kimball S, Fuleihan G, Vieth R. Vitamin D: A growing perspective. Crit Rev Clin Lab Sci 2008;45:339-414.
34. Ish-Shalom S, Segal E, Salganik T, Raz B, Bromberg IL, Vieth R. Comparison of daily, weekly, and monthly vitamin d3 in ethanol dosing protocols for two months in elderly hip fracture patients. J Clin Endocrinol Metab 2008;93: 3430-5.
35. Tuohimaa P, Tenkanen L, Ahonen M et al. Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: A longitudinal, nested case-control study in the Nordic countries. Int J Cancer 2004;108: 104-8.
36. McCullough ML, Weinstein SJ, Freedman DM et a l. Correlates of circulating 25-hydroxyvitamin D: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 2010;172:21-35.
37. Vieth R. How to Optimize Vitamin D Supplementation to Prevent Cancer, Based on Cellular Adaptation and Hydroxylase Enzymology. Anticancer Research 2009.
38. Michaelsson K, Baron JA, Snellman G et a l. Plasma vitamin D and mortality in older men: A communitybased prospective cohort study. Am J Clin Nutr 2010;92: 841-8.
39. Autier P, Gandini S. Vitamin D supplementation and total mortality: A meta-analysis of randomized controlled trials. Arch Intern Med 2007;167:1730-7.
40. Priemel M, von DC, Klatte TO et a l. Bone mineralization defects and vitamin D defi ciency: Histomorphometric analysis of iliac crest bone biopsies and circulating 25- hydroxyvitamin D in 675 patients. J Bone Miner Res 2010; 25:305-12.
41. Grimnes G, Joakimsen R, Figenschau Y, Torjesen PA, Almas B, Jorde R. The effect of high-dose vitamin D on bone mineral density and bone turnover markers in postmenopausal women with low bone mass-a randomized controlled 1-year trial. Osteoporos Int 2012;23:201-11.
42. Jorde R, Figenschau Y, Emaus N, Hutchinson M, Grimnes G. Serum 25-hydroxyvitamin D levels are strongly related to systolic blood pressure but do not predict future hypertension. Hypertension 2010;55:792-8.
43. Vieth R. Why the minimum desirable serum 25- hydroxyvitamin D level should be 75 nmol/L (30 ng/ml). Best Pract Res Clin Endocrinol Metab 2011;25: 681-91.
44. Bouillon R. Why modest but widespread improvement of the vitamin D status is the best strategy? Best Pract Res Clin Endocrinol Metab 2011;25:693-702.